SIVA-1 enhances acquired chemotherapeutic drug resistance of gastric cancer in vivo by regulating the ARF/MDM2/p53 pathway
Author:
Wang Xiao-Tong, Li Lei, Zhu Zhou, Huang Yu-LiangORCID, Chen Huan-Huan, Shi Zheng-Yi, Deng Qiao-Ming, Wu Kun, Xia Long-Jie, Mai Wei, Yang Jian-Rong, Kong Fan-Biao
Subject
Multidisciplinary
Reference30 articles.
1. Chen S, Wu J, Jiao K, Wu Q, Ma J, Chen D, Kang J, Zhao G, Shi Y, Fan D, et al: MicroRNA-495-3p inhibits multidrug resistance by modulating autophagy through GRP78/mTOR axis in gastric cancer. Cell Death Dis. 9(11):1070. doi:10.1038/s41419-018-0950-x. 2. Overexpression of CDX2 in gastric cancer cells promotes the development of multidrug resistance;Yan;Am. J. Cancer Res.,2014 3. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to SIVA, a proapoptotic protein;Prasad;Proc. Natl. Acad. Sci. U. S. A.,1997 4. SIVA 1 inhibits proliferation, migration and invasion by phosphorylating Stathmin in ovarian cancer cells;Ma;Oncol. Lett.,2017 5. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis;Chu;Apoptosis,2004
|
|